New therapeutic approaches for cystic fibrosis lung disease

J R Soc Med. 2002;95 Suppl 41(Suppl 41):58-67.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenoviridae
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticoagulants / therapeutic use
  • Bacterial Adhesion / drug effects
  • Bacterial Vaccines
  • Biofilms / drug effects
  • Cystic Fibrosis / therapy*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Genetic Therapy / methods
  • Genetic Vectors
  • Heparin / therapeutic use
  • Humans
  • Ion Transport
  • Mutation / genetics
  • Protease Inhibitors / therapeutic use
  • Pseudomonas Infections / prevention & control

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticoagulants
  • Bacterial Vaccines
  • CFTR protein, human
  • Protease Inhibitors
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Heparin